Rakovina Therapeutics Announces Results from 2026 Annual General Meeting

Preview text: Rakovina Therapeutics Announces Results from 2026 Annual General Meeting Rakovina…

Wednesday, Aug 19, 2026 at 7:01 AM EasternMailchimp

Rakovina TherapeuticsRakovina Therapeutics Announces Results from 2026 Annual General Meeting

Image not available

No image available for this email.

Subject: Rakovina Therapeutics Announces Results from 2026 Annual General Meeting
Preview text: Rakovina Therapeutics Announces Results from 2026 Annual General Meeting Rakovina…
From: ir@rakovinatherapeutics.com
Brand: Rakovina Therapeutics
ESP: Mailchimp
Sent: Wed Aug 19, 2026, 7:01 AM ET
Size: 69 KB
Images: 7
Links: 10, 2 of them buttons
Subject length: 72 characters

Against Rakovina Therapeutics's usual

Sent in the 7 AM hour, which holds 6% of its emails; 31% arrive in the 4 PM hour. The subject is 72 characters; its average is 70.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: Rakovina Therapeutics <[email protected]>
Reply-To: Rakovina Therapeutics <[email protected]>
Subject: Rakovina Therapeutics Announces Results from 2026 Annual General Meeting
Date: Wed, 19 Aug 2026 11:01:06 +0000
Message-ID domain: mail148.suw161.rsgsv.net
Return-Path domain: mail148.suw161.rsgsv.net
DKIM signature: d=mailchimpapp.net s=k3
List-Unsubscribe: Present, one-click
Mailer: Mailchimp Mailer
Feedback-ID sender: mc

Other sending headers (names only): X-Campaign, X-campaignid, X-Report-Abuse, X-MC-User, X-Accounttype

	Sep 10, 2026 4:30 AM	Rakovina Therapeutics Announces Appointment of Professor Petra Hamerlik to its Board of Directors
	Aug 31, 2026 7:00 PM	Rakovina Therapeutics Announces Q2 2026 Financial Results and Provides Corporate Update
	Aug 31, 2026 4:42 PM	Rakovina Therapeutics Announces Final Closing of Upsized Non-Brokered Private Placement
	Aug 19, 2026 7:01 AM	Rakovina Therapeutics Announces Results from 2026 Annual General Meeting (this email)
	Aug 12, 2026 4:30 AM	Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement
	Aug 2, 2026 4:01 PM	New AI Collaboration: Expanding Drug Discovery with Variational AI's Enki™ Platform
	Jul 29, 2026 3:59 PM	How AI is Revolutionizing DDR-Based Cancer Therapies at Rakovina Therapeutics